These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10712162)

  • 1. P2Y receptors: in the middle of the road.
    Boeynaems JM; Communi D; Savi P; Herbert JM
    Trends Pharmacol Sci; 2000 Jan; 21(1):1-3. PubMed ID: 10712162
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor.
    Feng C; Mery AG; Beller EM; Favot C; Boyce JA
    J Immunol; 2004 Dec; 173(12):7539-47. PubMed ID: 15585881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in the research of P2Y receptor].
    Mei L; Fang WG
    Sheng Li Ke Xue Jin Zhan; 2005 Apr; 36(2):155-8. PubMed ID: 16222979
    [No Abstract]   [Full Text] [Related]  

  • 5. P2Y(1) and P2Y(2) receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed.
    Buvinic S; Briones R; Huidobro-Toro JP
    Br J Pharmacol; 2002 Jul; 136(6):847-56. PubMed ID: 12110609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heteromeric association creates a P2Y-like adenosine receptor.
    Yoshioka K; Saitoh O; Nakata H
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7617-22. PubMed ID: 11390975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of P2Y receptors in the differentiation of haematopoietic cells.
    Sak K; Boeynaems JM; Everaus H
    J Leukoc Biol; 2003 Apr; 73(4):442-7. PubMed ID: 12660218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signalling mechanisms involved in P2Y receptor-mediated reactive astrogliosis.
    Abbracchio MP; Brambilla R; Ceruti S; Cattabeni F
    Prog Brain Res; 1999; 120():333-42. PubMed ID: 10551009
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular biology of P2Y receptors expressed in the nervous system.
    Webb TE; Barnard EA
    Prog Brain Res; 1999; 120():23-31. PubMed ID: 10550985
    [No Abstract]   [Full Text] [Related]  

  • 10. [Research Progress on Expression and Function of P2 Purinergic Receptor in Blood Cells].
    Feng WL; Wang LN; Zheng GG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1517-22. PubMed ID: 26524069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a P2Y-purinergic receptor that inhibits adenylyl cyclase.
    Boyer JL; Lazarowski ER; Chen XH; Harden TK
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1140-6. PubMed ID: 8263774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors.
    Koizumi S; Ohsawa K; Inoue K; Kohsaka S
    Glia; 2013 Jan; 61(1):47-54. PubMed ID: 22674620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2Y receptors in the nervous system: molecular studies of a P2Y2 receptor subtype from NG108-15 neuroblastoma x glioma hybrid cells.
    Weisman GA; Garrad RC; Erb LJ; Santos-Berrios C; Gonzalez FA
    Prog Brain Res; 1999; 120():33-43. PubMed ID: 10550986
    [No Abstract]   [Full Text] [Related]  

  • 14. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
    Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
    Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction: P2 receptors.
    Burnstock G
    Curr Top Med Chem; 2004; 4(8):793-803. PubMed ID: 15078211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2Y receptors: focus on structural, pharmacological and functional aspects in the brain.
    Fischer W; Krügel U
    Curr Med Chem; 2007; 14(23):2429-55. PubMed ID: 17979698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pharmacology of P2Y-receptors.
    von Kügelgen I; Wetter A
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):310-23. PubMed ID: 11111826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal P2 receptors of the central nervous system.
    Illes P; Ribeiro JA
    Curr Top Med Chem; 2004; 4(8):831-8. PubMed ID: 15078214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine purinergic receptor signaling is essential for macrophage chemotaxis.
    Kronlage M; Song J; Sorokin L; Isfort K; Schwerdtle T; Leipziger J; Robaye B; Conley PB; Kim HC; Sargin S; Schön P; Schwab A; Hanley PJ
    Sci Signal; 2010 Jul; 3(132):ra55. PubMed ID: 20664064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y and P2U receptors differentially release intracellular Ca2+ via the phospholipase c/inositol 1,4,5-triphosphate pathway in astrocytes from the dorsal spinal cord.
    Idestrup CP; Salter MW
    Neuroscience; 1998 Oct; 86(3):913-23. PubMed ID: 9692727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.